Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Colombia — National Food and Drug Surveillance Institute

Tracked across 2 events · 13 articles · First seen Sep 01, 2026 · Last active Sep 08, 2026

Sentiment
0
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Regulatory
Impact: Colombia — National Food and Drug Surveillance Institute, Colombia's health regulatory agency, granted approval for TAVALISSE, fulfilling its role in evaluating and authorizing pharmaceutical products for the Colombian market.
Sep 01, 2026 · 7 articles
1 0
Business
Regenerative Medical Technology Group, Inc. (RMTG), through its Cellgenic division, announced on September 8, 2026, that it has commenced local commercial arrangements in Colombia, including establishing local representation and developing relationships with physicians and medical…
Impact: Colombian regulator; approvals needed for product registration.
Sep 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Colombia — National Food and Drug Surveillance Institute live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.